Trending Now
Business
General Electric: POOF! There Goes The Moat
General Electric (GE) reported Q2 revenue of $28.83 billion, Non-GAAP EPS of $0.17, and GAAP EPS of -$0.03. The company beat on Non-GAAP EPS...
General Electric: Did ‘Run On The Bank’ Force A GECAS Sale?
Shares in General Electric (GE) spiked more than 6% Monday on market chatter that Apollo Global Management was interested in acquiring GE Capital Aviation...
Lifestyle today
Entertainment
SHAM! Allergan Says Mohawks Bought $14 Billion Patents With Immunity Promise
Allergan's odd patent transfer to the St. Regis Mohawk Tribe is gaining a lot of scrutiny. It sued rivals from offering generic Restasis, its...
Katt Williams, Will Smith Freestyle At Dave Chappelle Comedy Event
Comedian Dave Chappelle is known for putting unknown stars on like Charlie Murphy, Donnell Rawlins on. He is also known for being a conduit...
Impersonating ‘Shock Exchange’, Jeffrey Gunlach Predicts 2020 Recession
Recessionary signals are everyone. RV shipments are falling, the labor participation rate is extremely low, over 95 million are no longer in the work...
Cornel West Announces Bid For President
The 2024 presidential election is heating up, though the election is year away. President Joe Biden will seek re-election, and his is...
Sell CSX Into Earnings
CSX Corporation (CSX) reports quarterly earnings January 16th. Analysts expect revenue of $3.14 billion and EPS of $0.99. The revenue estimate implies flat revenue...
Mallinckrodt: Is The Generics Sale In Trouble?
In March 2017 Mallinckrodt (MNK) announced it was exploring the sale of its generics business in a deal that could have fetched values as...
Valeant’s Talc / Ovarian Cancer Exposures Could Spell Major Trouble
Last week a California jury dropped a talc bombshell on Johnson & Johnson (JNJ), awarding $417 million to a 63-year old woman who claimed...
Mavyret Could Amplify Gilead’s HCV Pain
An HCV price war between Gilead (GILD) and AbbVie (ABBV) could heat up. AbbVie recently received FDA approval for Mavyret, its new HCV drug....
























































































































